208 related articles for article (PubMed ID: 20837697)
1. Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner.
Kranich J; Krautler NJ; Falsig J; Ballmer B; Li S; Hutter G; Schwarz P; Moos R; Julius C; Miele G; Aguzzi A
J Exp Med; 2010 Sep; 207(10):2271-81. PubMed ID: 20837697
[TBL] [Abstract][Full Text] [Related]
2. TGFβ1 increases microglia-mediated engulfment of apoptotic cells via upregulation of the milk fat globule-EGF factor 8.
Spittau B; Rilka J; Steinfath E; Zöller T; Krieglstein K
Glia; 2015 Jan; 63(1):142-53. PubMed ID: 25130376
[TBL] [Abstract][Full Text] [Related]
3. Complement 3
Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
[TBL] [Abstract][Full Text] [Related]
4. Flow Cytometric Detection of PrP
Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory response of microglia to prions is controlled by sialylation of PrP
Srivastava S; Katorcha E; Makarava N; Barrett JP; Loane DJ; Baskakov IV
Sci Rep; 2018 Jul; 8(1):11326. PubMed ID: 30054538
[TBL] [Abstract][Full Text] [Related]
6. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
[TBL] [Abstract][Full Text] [Related]
7. Microglia in the degenerating brain are capable of phagocytosis of beads and of apoptotic cells, but do not efficiently remove PrPSc, even upon LPS stimulation.
Hughes MM; Field RH; Perry VH; Murray CL; Cunningham C
Glia; 2010 Dec; 58(16):2017-30. PubMed ID: 20878768
[TBL] [Abstract][Full Text] [Related]
8. A versatile prion replication assay in organotypic brain slices.
Falsig J; Julius C; Margalith I; Schwarz P; Heppner FL; Aguzzi A
Nat Neurosci; 2008 Jan; 11(1):109-17. PubMed ID: 18066056
[TBL] [Abstract][Full Text] [Related]
9. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation.
Sakai K; Hasebe R; Takahashi Y; Song CH; Suzuki A; Yamasaki T; Horiuchi M
J Virol; 2013 Dec; 87(24):13433-45. PubMed ID: 24089559
[TBL] [Abstract][Full Text] [Related]
10. Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.
Chen C; Xu XF; Zhang RQ; Ma Y; Lv Y; Li JL; Shi Q; Xiao K; Sun J; Yang XD; Shi Q; Dong XP
Prion; 2017 Sep; 11(5):338-351. PubMed ID: 28956708
[TBL] [Abstract][Full Text] [Related]
11. Unaltered prion disease in mice lacking developmental endothelial locus-1.
Zhu C; Li Z; Li B; Pfammatter M; Hornemann S; Aguzzi A
Neurobiol Aging; 2019 Apr; 76():208-213. PubMed ID: 30743056
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth Factor.
Howangyin KY; Zlatanova I; Pinto C; Ngkelo A; Cochain C; Rouanet M; Vilar J; Lemitre M; Stockmann C; Fleischmann BK; Mallat Z; Silvestre JS
Circulation; 2016 Mar; 133(9):826-39. PubMed ID: 26819373
[TBL] [Abstract][Full Text] [Related]
13. MFGE8 does not orchestrate clearance of apoptotic neurons in a mouse model of Parkinson's disease.
Kinugawa K; Monnet Y; Lu L; Bekaert AJ; Théry C; Mallat Z; Hirsch EC; Hunot S
Neurobiol Dis; 2013 Mar; 51():192-201. PubMed ID: 23194669
[TBL] [Abstract][Full Text] [Related]
14. Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time.
Mayer-Sonnenfeld T; Avrahami D; Friedman-Levi Y; Gabizon R
Cell Mol Neurobiol; 2008 Nov; 28(7):1005-15. PubMed ID: 18350378
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte-to-neuron intercellular prion transfer is mediated by cell-cell contact.
Victoria GS; Arkhipenko A; Zhu S; Syan S; Zurzolo C
Sci Rep; 2016 Feb; 6():20762. PubMed ID: 26857744
[TBL] [Abstract][Full Text] [Related]
16. Molecular signatures in prion disease: altered death receptor pathways in a mouse model.
Giri RK
J Transl Med; 2024 May; 22(1):503. PubMed ID: 38802941
[TBL] [Abstract][Full Text] [Related]
17. Small-ruminant lentivirus enhances PrPSc accumulation in cultured sheep microglial cells.
Stanton JB; Knowles DP; O'Rourke KI; Herrmann-Hoesing LM; Mathison BA; Baszler TV
J Virol; 2008 Oct; 82(20):9839-47. PubMed ID: 18684809
[TBL] [Abstract][Full Text] [Related]
18. Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
Mays CE; van der Merwe J; Kim C; Haldiman T; McKenzie D; Safar JG; Westaway D
J Virol; 2015 Dec; 89(24):12418-26. PubMed ID: 26423957
[TBL] [Abstract][Full Text] [Related]
19. Prion protein functions and dysfunction in prion diseases.
Sakudo A; Ikuta K
Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
[TBL] [Abstract][Full Text] [Related]
20. A systems approach to prion disease.
Hwang D; Lee IY; Yoo H; Gehlenborg N; Cho JH; Petritis B; Baxter D; Pitstick R; Young R; Spicer D; Price ND; Hohmann JG; Dearmond SJ; Carlson GA; Hood LE
Mol Syst Biol; 2009; 5():252. PubMed ID: 19308092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
